Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

por Yamamoto, N, Fukuoka, M, Negoro, S-I, Nakagawa, K, Saito, H, Matsui, K, Kawahara, M, Senba, H, Takada, Y, Kudoh, S, Nakano, T, Katakami, N, Sugiura, T, Hoso, T, Ariyoshi, Y
Publicado 2004